Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Foxroids.com
WARNING LETTER
•Foxroids.com•April 17, 2020

Foxroids.com – FDA Warning Letter, Apr 17, 2020

Record Details

On April 22, 2020, the FDA issued a Warning Letter to www.foxroids.com after reviewing its website on April 17, 2020. The FDA found the company was unlawfully selling unapproved and misbranded drug products online, claiming they could mitigate, prevent, treat, diagnose, or cure Coronavirus Disease 2019 (COVID-19) during a declared public health emergency. Specific products cited include "Lopimune 200mg/50 mg," "Ritomune 100 mg," "Fluvir 75 mg," and "Antiflu 75mg," all marketed under a "Coronavirus Treatment" heading. These products are deemed unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), as no approved applications exist for their COVID-19 related uses, and they are not generally recognized as safe and effective. Additionally, they are misbranded drugs under section 502 (21 U.S.C. § 352). The introduction or delivery of these prohibited products into interstate commerce violates sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)). The FDA stressed the inherent risks of unapproved drugs, which lack assurances of safety and effectiveness. The company must immediately cease selling these products and respond within 48 hours via email to COVID-19-Task-Force-CDER@fda.hhs.gov, detailing corrective actions, steps to prevent recurrence, and supporting documentation. Failure to comply could result in legal action, including seizure and injunction, and products may be refused admission into the U.S.

Company
Foxroids.com
Inspection date
April 17, 2020
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Donald D. Ashley (Director)
View Company Profile

ID · b63ec862-afc0-4e41-bc9f-9c9b4c9b1c0f

Violation Codes7
21 U.S.C. 321(g)21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 35221 U.S.C. 331(d)21 U.S.C. 321(p)21 U.S.C. 360bbb-3

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Foxroids.com
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.